Randomized trial of primary debulking surgery versus neoadjuvant chemotherapy for advanced epithelial ovarian cancer (SCORPION-NCT01461850).
Fagotti A, Ferrandina MG, Vizzielli G, Pasciuto T, Fanfani F, Gallotta V, Margariti PA, Chiantera V, Costantini B, Gueli Alletti S, Cosentino F, Scambia G.
Int J Gynecol Cancer. 2020 Nov;30(11):1657-1664. doi: 10.1136/ijgc-2020-001640. Epub 2020 Oct 7.
Laparoscopic Cytoreduction After Neoadjuvant Chemotherapy in High-Grade Epithelial Ovarian Cancer: A LANCE Randomized Clinical Trial.
Rauh-Hain JA, Melamed A, Pareja R, May T, Sinno A, McNally L, Horowitz NS, De Iaco P, Michener CM, Van Lonkhuijzen L, Iniesta MD, Yuan Y, Ramirez PT, Fagotti A.
JAMA Netw Open. 2024 Nov 4;7(11):e2446325. doi: 10.1001/jamanetworkopen.2024.46325.
A laparoscopy-based score to predict surgical outcome in patients with advanced ovarian carcinoma: a pilot study.
Fagotti A, Ferrandina G, Fanfani F, Ercoli A, Lorusso D, Rossi M, Scambia G.
Ann Surg Oncol. 2006 Aug;13(8):1156-61. doi: 10.1245/ASO.2006.08.021. Epub 2006 Jun 21.
Expert consensus: Profiling and management of advanced or metastatic epithelial ovarian cancer.
Pierre ME, Manneh R, Hernández A, Rodríguez J, Fletcher AV, Ramírez HM, Niño OM, Gómez DA, Sanabria D, Contreras F, Pieschacón JR, Calderón PH.
Rev Colomb Obstet Ginecol. 2024 Jun 14;75(1):4094. doi: 10.18597/rcog.4094.
Laparoscopic prediction of primary cytoreducibility of epithelial ovarian cancer.
Golia D'Augè T, Cuccu I, DE Angelis E, DI Donato V, Muzii L, D'Oria O, Chiantera V, Gerli S, Caserta D, Besharat AR, Laganà AS, Bogani G, Favilli A, Giannini A.
Minerva Obstet Gynecol. 2024 Dec;76(6):548-557. doi: 10.23736/S2724-606X.24.05452-6. Epub 2024 Oct 8.
Laparoscopic Surgical Algorithm to Triage the Timing of Tumor Reductive Surgery in Advanced Ovarian Cancer.
Fleming ND, Nick AM, Coleman RL, Westin SN, Ramirez PT, Soliman PT, Fellman B, Meyer LA, Schmeler KM, Lu KH, Sood AK.
Obstet Gynecol. 2018 Sep;132(3):545-554. doi: 10.1097/AOG.0000000000002796.
Advanced ovarian cancer.
Chi DS, Sabbatini P.
Curr Treat Options Oncol. 2000 Jun;1(2):139-46. doi: 10.1007/s11864-000-0058-1.
Feasibility of laparoscopic cytoreduction in patients with localized recurrent epithelial ovarian cancer.
Paik ES, Lee YY, Kim TJ, Choi CH, Lee JW, Kim BG, Bae DS.
J Gynecol Oncol. 2016 May;27(3):e24. doi: 10.3802/jgo.2016.27.e24.
Laparoscopic Assessment to Determine the Likelihood of Achieving Optimal Cytoreduction in Patients Undergoing Primary Debulking Surgery for Ovarian, Fallopian Tube, or Primary Peritoneal Cancer.
Andikyan V, Kim A, Gretz HF 3rd, Zakashansky K, Prasad-Hayes M, Beddoe AM, Dottino P, Mandeli J, Chuang L.
Am J Clin Oncol. 2018 Oct;41(10):938-942. doi: 10.1097/COC.0000000000000413.
Upping the ante in assessing the feasibility of surgical cytoreduction for advanced ovarian cancer: a modified laparoscopic Predictive Index score.
Ramirez PT.
Gynecol Oncol. 2015 Oct;139(1):1-2. doi: 10.1016/j.ygyno.2015.09.014.
